Cargando…

ODP391 Neurodevelopmental and Growth Outcome of Congenital Hypothyroidism: A National Investigation of Birth Cohort Study

OBJECTIVES: The purpose was to investigate the neurodevelopmental and growth status of Congenital hypothyroidism (CH) patients compared to normal children using population-based cohort study. METHODS: The National Investigation of Birth Cohort in Korea study 2008 (NICKs-2008) consisted of the Korean...

Descripción completa

Detalles Bibliográficos
Autores principales: Jung, Mo Kyung, Cha, Hye Ryeong, Lee, Seung Won, Ha, Eun Kyo, Kim, Ju Hee, Yoo, Eun-Gyong, Han, Man Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625640/
http://dx.doi.org/10.1210/jendso/bvac150.1255
_version_ 1784822550063218688
author Jung, Mo Kyung
Cha, Hye Ryeong
Lee, Seung Won
Ha, Eun Kyo
Kim, Ju Hee
Yoo, Eun-Gyong
Han, Man Yong
author_facet Jung, Mo Kyung
Cha, Hye Ryeong
Lee, Seung Won
Ha, Eun Kyo
Kim, Ju Hee
Yoo, Eun-Gyong
Han, Man Yong
author_sort Jung, Mo Kyung
collection PubMed
description OBJECTIVES: The purpose was to investigate the neurodevelopmental and growth status of Congenital hypothyroidism (CH) patients compared to normal children using population-based cohort study. METHODS: The National Investigation of Birth Cohort in Korea study 2008 (NICKs-2008) consisted of the Korean National Health Insurance System (NHIS) and the National Health Screening Program for Infants and Children (NHSPIC) databases comprising children born in 2008 (n=469,248) and 2009 (n=448,459). The CH patients were enrolled with International Classifications of Diseases-10 codes and drug classification (levothyroxine over 5 years) codes. We investigated their developmental outcomes using the Korean-Ages and Stages Questionnaire (K-ASQ), and serial changes of BMI (BMI-z) and height (height -z) were compared in children with and without CH. Risk ratios were obtained using a modified Poisson regression and weighted risk differences using binomial regression. RESULTS: Of the 919,707 newborns, 433 children (boys, 47.7%) were diagnosed as CH (1: 2,124 of prevalence). The risk ratio (RR) for delayed development based on the results from the 5th–7th K-ASQ was higher for the total developmental area (adjusted RR = 2.77, 95% CI: 1.507-5.118) in CH patients. There was significant difference between patients with CH and controls in the assessment of gross motor, fine motor and problem-solving areas (P < . 0001). At 66-71 months of age, short stature (height-z < -1.63) were increased in the CH group compared with normal children (adjusted RR 2.27, 95% CI 1.328-3.865). Obese children (BMI-z > 1.63) were not increased. CONCLUSIONS: The adequate large cohort data showed that prevalence of developmental delay and short stature were higher in CH patients than normal. Careful and early intervention is needed. Presentation: No date and time listed
format Online
Article
Text
id pubmed-9625640
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-96256402022-11-14 ODP391 Neurodevelopmental and Growth Outcome of Congenital Hypothyroidism: A National Investigation of Birth Cohort Study Jung, Mo Kyung Cha, Hye Ryeong Lee, Seung Won Ha, Eun Kyo Kim, Ju Hee Yoo, Eun-Gyong Han, Man Yong J Endocr Soc Pediatric Endocrinology OBJECTIVES: The purpose was to investigate the neurodevelopmental and growth status of Congenital hypothyroidism (CH) patients compared to normal children using population-based cohort study. METHODS: The National Investigation of Birth Cohort in Korea study 2008 (NICKs-2008) consisted of the Korean National Health Insurance System (NHIS) and the National Health Screening Program for Infants and Children (NHSPIC) databases comprising children born in 2008 (n=469,248) and 2009 (n=448,459). The CH patients were enrolled with International Classifications of Diseases-10 codes and drug classification (levothyroxine over 5 years) codes. We investigated their developmental outcomes using the Korean-Ages and Stages Questionnaire (K-ASQ), and serial changes of BMI (BMI-z) and height (height -z) were compared in children with and without CH. Risk ratios were obtained using a modified Poisson regression and weighted risk differences using binomial regression. RESULTS: Of the 919,707 newborns, 433 children (boys, 47.7%) were diagnosed as CH (1: 2,124 of prevalence). The risk ratio (RR) for delayed development based on the results from the 5th–7th K-ASQ was higher for the total developmental area (adjusted RR = 2.77, 95% CI: 1.507-5.118) in CH patients. There was significant difference between patients with CH and controls in the assessment of gross motor, fine motor and problem-solving areas (P < . 0001). At 66-71 months of age, short stature (height-z < -1.63) were increased in the CH group compared with normal children (adjusted RR 2.27, 95% CI 1.328-3.865). Obese children (BMI-z > 1.63) were not increased. CONCLUSIONS: The adequate large cohort data showed that prevalence of developmental delay and short stature were higher in CH patients than normal. Careful and early intervention is needed. Presentation: No date and time listed Oxford University Press 2022-11-01 /pmc/articles/PMC9625640/ http://dx.doi.org/10.1210/jendso/bvac150.1255 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the Endocrine Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Pediatric Endocrinology
Jung, Mo Kyung
Cha, Hye Ryeong
Lee, Seung Won
Ha, Eun Kyo
Kim, Ju Hee
Yoo, Eun-Gyong
Han, Man Yong
ODP391 Neurodevelopmental and Growth Outcome of Congenital Hypothyroidism: A National Investigation of Birth Cohort Study
title ODP391 Neurodevelopmental and Growth Outcome of Congenital Hypothyroidism: A National Investigation of Birth Cohort Study
title_full ODP391 Neurodevelopmental and Growth Outcome of Congenital Hypothyroidism: A National Investigation of Birth Cohort Study
title_fullStr ODP391 Neurodevelopmental and Growth Outcome of Congenital Hypothyroidism: A National Investigation of Birth Cohort Study
title_full_unstemmed ODP391 Neurodevelopmental and Growth Outcome of Congenital Hypothyroidism: A National Investigation of Birth Cohort Study
title_short ODP391 Neurodevelopmental and Growth Outcome of Congenital Hypothyroidism: A National Investigation of Birth Cohort Study
title_sort odp391 neurodevelopmental and growth outcome of congenital hypothyroidism: a national investigation of birth cohort study
topic Pediatric Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625640/
http://dx.doi.org/10.1210/jendso/bvac150.1255
work_keys_str_mv AT jungmokyung odp391neurodevelopmentalandgrowthoutcomeofcongenitalhypothyroidismanationalinvestigationofbirthcohortstudy
AT chahyeryeong odp391neurodevelopmentalandgrowthoutcomeofcongenitalhypothyroidismanationalinvestigationofbirthcohortstudy
AT leeseungwon odp391neurodevelopmentalandgrowthoutcomeofcongenitalhypothyroidismanationalinvestigationofbirthcohortstudy
AT haeunkyo odp391neurodevelopmentalandgrowthoutcomeofcongenitalhypothyroidismanationalinvestigationofbirthcohortstudy
AT kimjuhee odp391neurodevelopmentalandgrowthoutcomeofcongenitalhypothyroidismanationalinvestigationofbirthcohortstudy
AT yooeungyong odp391neurodevelopmentalandgrowthoutcomeofcongenitalhypothyroidismanationalinvestigationofbirthcohortstudy
AT hanmanyong odp391neurodevelopmentalandgrowthoutcomeofcongenitalhypothyroidismanationalinvestigationofbirthcohortstudy